We are pleased to announce that Journal of Vascular Diseases (ISSN: 2813-2475) has been selected for coverage in the Emerging Sources Citation Index (ESCI) in Web of Science.
Find out more about submitting a manuscript to JVD: buff.ly/QAYnJGt
#mdpi #openaccess #vasculardiseases #research
This review highlights how #HDACs regulate endothelial and #SmoothMuscleCells and contribute to #Vascular #Pathogenesis. It also explores the therapeutic promise of HDAC inhibitors in #VascularDiseases. #medsky
#OpenAccess: www.sciencedirect.com/science/arti...
This is more than a step forward for MSMDS.
It’s a proof of concept that our rare disease can lead the way to treatments for other severe vascular diseases, like Moyamoya.
#vasculardiseases
Cross-border healthcare within the #EU? The "European Reference Networks for Rare Diseases" (ERNs) make that possible! There are 24 ERNs, co-funded by the @ec.europa.eu. Meet @vascern.bsky.social - the experts on Rare Multisystemic #VascularDiseases
Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis
A review on the physiological & pathological role of HDACs in regulating vascular homeostasis & vascular diseases, respectively, with a discussion on the therapeutic effect of #HDAC inhibitors on #VascularDiseases. #Epigenetics
#OpenAccess : https://buff.ly/3PNGaaF
Researchers of the Markus Affolter lab @biozentrum.bsky.social have uncovered new mechanisms in #bloodvessel formation, showing the interaction of cells and the critical role of dynamic forces. Interesting also for treatment of #vasculardiseases. @unibas.ch #angiogenesis ow.ly/gkzE50Usmbh
